RESUMEN DEL MERCADO
Los biorreactores de bioprocesamiento portátiles son dispositivos que imitan un entorno bioquímico natural en los laboratorios para el crecimiento óptimo de células o tejidos en cultivos microbianos y celulares. Proporciona control sobre varios parámetros como temperatura, humedad, pH, oxígeno y velocidad de agitación para producir los resultados más satisfactorios, como maximizar el crecimiento celular y la productividad. El principal objetivo del biorreactor de bioprocesamiento portátil es reducir los pasos complejos que ocurren en los biorreactores de bioprocesamiento tradicionales. Es un dispositivo compacto, fácil de usar y automatizado que requiere poco espacio para encajar.ÁMBITO DEL MERCADO
El "Análisis del mercado global de biorreactores de bioprocesamiento portátiles hasta 2028" es un estudio especializado y en profundidad del sector sanitario industria con un enfoque especial en el análisis de tendencias del mercado global. El informe tiene como objetivo proporcionar una descripción general del mercado de biorreactores de bioprocesamiento portátiles con una segmentación detallada del mercado por capacidad, material, tipo de control, usuario final y geografía. El informe proporciona estadísticas clave sobre el estado del mercado de los principales actores del mercado de biorreactores de bioprocesamiento portátiles y ofrece tendencias y oportunidades clave en el mercado.SEGMENTACIÓN DEL MERCADO
- • Según la capacidad, el mercado mundial de biorreactores de bioprocesamiento portátiles se segmenta en 1-10 L, 10-50 L, 50-100 L y 100-500 L. • En función del material, el mercado se segmenta en vidrio, acero inoxidable y de un solo uso. • Según el tipo de control, el mercado se divide en automatizado y manual. • Según los usuarios finales, el mercado se divide en industria biofarmacéutica, institutos académicos y laboratorios de investigación.
DINÁMICA DEL MERCADO
Impulsores:
- • Creciente desarrollo de las áreas de investigación e industria biofarmacéutica. • Aumento de la demanda de biorreactores de alta eficiencia y que requieran menos espacio. •Avances tecnológicos en biorreactores.
Restricciones:
- • Indisponibilidad de profesionales capacitados. •Requisito de alto mantenimiento de los biorreactores portátiles de bioprocesamiento.
MARCO REGIONAL
El informe proporciona una descripción detallada de la industria que incluye información tanto cualitativa como cuantitativa. Proporciona una descripción general y una previsión del mercado global en función de varios segmentos. También proporciona el tamaño del mercado y estimaciones de pronóstico del año 2019 al 2028 con respecto a cinco regiones principales, a saber; América del Norte, Europa, Asia-Pacífico (APAC), Medio Oriente y África (MEA) y América del Sur. El mercado de biorreactores de bioprocesamiento portátiles de cada región se subsegmenta posteriormente en los respectivos países y segmentos. El informe cubre el análisis y pronóstico de 18 países a nivel mundial junto con la tendencia actual y las oportunidades que prevalecen en la región. El informe analiza los factores que afectan al mercado tanto desde el lado de la demanda como de la oferta y evalúa en mayor profundidad la dinámica del mercado que afecta al mercado durante el período de pronóstico, es decir, impulsores, restricciones, oportunidades y tendencias futuras. El informe también proporciona un análisis PEST exhaustivo para las cinco regiones, a saber; América del Norte, Europa, APAC, MEA y América del Sur después de evaluar los factores políticos, económicos, sociales y tecnológicos que afectan el mercado de biorreactores de bioprocesamiento portátiles en estas regiones.IMPACTO DEL COVID-19 EN EL MERCADO DE BIORREACTORES DE BIOPROCESAMIENTO PORTÁTILES
El COVID-19 comenzó inicialmente en Wuhan (China) en diciembre de 2019 y, hasta ahora, se ha extendido a un ritmo rápido por todo el mundo. Estados Unidos, India, Brasil, Rusia, Francia, Reino Unido, Italia y España son algunos de los países más afectados en términos de casos confirmados y muertes reportadas. Con la creciente pandemia, muchas empresas biofarmacéuticas participan en el desarrollo de vacunas en respuesta a ella. En el sector médico, los biorreactores tienen una gran demanda. Esto genera oportunidades lucrativas para las empresas dedicadas a este ámbito. Una disminución en el gasto en I+D farmacéutico y una caída en las ventas de productos biológicos en 2020 debido al bloqueo y el cierre de negocios impactaron significativamente el crecimiento del mercado de biorreactores de bioprocesamiento portátiles. Sin embargo, el aumento de la investigación y el desarrollo de vacunas ha aumentado la demanda de tecnologías de bioprocesamiento. Por lo tanto, debido a los factores mencionados anteriormente, la industria de la salud y las industrias de fabricación de bioprocesamiento se ven afectadas positivamente en términos de crecimiento, y el mercado general será testigo de un crecimiento sustancial en el período previsto.JUGADORES DEL MERCADO
El informe cubre desarrollos clave en el mercado de biorreactores de bioprocesamiento portátiles como estrategias de crecimiento orgánico e inorgánico. Varias empresas se están centrando en estrategias de crecimiento orgánico como lanzamientos de productos, aprobaciones de productos y otros como patentes y eventos. Las actividades de estrategias de crecimiento inorgánico observadas en el mercado fueron adquisiciones, asociaciones y colaboraciones. Estas actividades han allanado el camino para la expansión de los negocios y la base de clientes de los actores del mercado. Se prevé que los actores del mercado de biorreactores de bioprocesamiento portátiles tengan oportunidades de crecimiento lucrativas en el futuro con la creciente demanda de biorreactores de bioprocesamiento portátiles en el mercado global. El informe también incluye los perfiles de empresas clave junto con su análisis FODA y estrategias de mercado en el mercado de biorreactores de bioprocesamiento portátiles. Además, el informe se centra en los principales actores de la industria con información como perfiles de empresas, componentes y servicios ofrecidos, información financiera de los últimos 3 años, el desarrollo clave en los últimos cinco años.- • Merck & Co. Inc. • Thermo Fisher Scientific Inc. • GE Healthcare • Sartorius Stedim Biotech SA • Cesco Bioengineering Co., Ltd. • Eppendorf AG • Biosan Laboratories, Inc. • Laboratorio IKA • Cellexus Ltd. • Solaris Biotech Company
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Merck and Co. Inc.
2. Thermo Fisher Scientific Inc.
3. GE Healthcare
4. Sartorius Stedim Biotech SA
5. Cesco Bioengineering Co., Ltd.
6. Eppendorf AG
7. Biosan Laboratories, Inc.
8. IKA laboratory
9. Cellexus Ltd.
10. Solaris Biotech Company
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2024
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2024
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2024
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2024
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)